Concert Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-12,413
Closed -$1.82M 166
2017
Q1
$1.82M Sell
12,413
-3,408
-22% -$566K 0.41% 58
2016
Q4
$2.31M Sell
15,821
-4,917
-24% -$740K 0.51% 36
2016
Q3
$3.47M Sell
20,738
-547
-3% -$92.5K 0.42% 45
2016
Q2
$3.23M Buy
21,285
+1,048
+5% +$163K 0.44% 41
2016
Q1
$3.02M Sell
20,237
-363
-2% -$53.9K 0.4% 50
2015
Q4
$3.34M Buy
20,600
+982
+5% +$154K 0.45% 45
2015
Q3
$2.73M Sell
19,618
-403
-2% -$63.5K 0.37% 52
2015
Q2
$3.07M Sell
20,021
-175
-0.9% -$28K 0.4% 45
2015
Q1
$2.18M Buy
20,196
+546
+3% +$86K 0.62% 34
2014
Q4
$3.14M Buy
19,650
+8,165
+71% +$1.27M 0.48% 38
2014
Q3
$1.61M Sell
11,485
-488
-4% -$63.7K 0.22% 69
2014
Q2
$1.37M Buy
11,973
+132
+1% +$15.3K 0.17% 84
2014
Q1
$1.42M Sell
11,841
-527
-4% -$63.9K 0.18% 82
2013
Q4
$1.4M Sell
12,368
-110
-0.9% -$12.5K 0.18% 87
2013
Q3
$1.39M Sell
12,478
-834
-6% -$90.4K 0.2% 76
2013
Q2
$1.32M Buy
+13,312
New +$1.38M 0.2% 68

Other funds holding AMGN

Concert Wealth Management's AMGN Position: Q2 2017 in Review

Concert Wealth Management sold out of Amgen (AMGN) in Q2 2017, closing a stake of 12,413 shares — an estimated $1.82M sold.

Concert Wealth Management first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $3.47M in Q3 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Concert Wealth Management reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 12,413 Amgen shares in Q2 2017, an estimated $1.82M.
  • Concert Wealth Management first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Amgen position peaked at $3.47M in Q3 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.